Global Gastro Esophageal Reflux Disease (GERD) Drug and Devices Market -Analysis and Forecast (2017-2023) (Focus on Device Type, Drug Type, Market Share Analysis, Patent Landscape and Country Analysis)

Global Gastro Esophageal Reflux Disease (GERD) Drug and Devices Market -Analysis and Forecast (2017-2023) (Focus on Device Type, Drug Type, Market Share Analysis, Patent Landscape and Country Analysis)

Gastro-Esophageal Reflux Disease (GERD) therapy isused to treat one of the most common & chronic gastric disease, GERD, that effects the quality of life of patients. GERD is the regurgitation of gastric contents into the esophagus. Since esophagus is not designed to tolerate the acidic contents of the stomach, the backflow causes damage to it. The treatment aims to eliminate the symptoms such as heartburn, acidic taste in mouth, hoarseness, dry cough, asthma etc & cure the disease. The disease, if not treated, may lead to strictures, ulcers & predisposes to cancerous conditions. The GERD therapy market comprises of an array of treatments consisting of medications, devices & surgery.

The GERD therapy market is an already established market, in which a number of the drugs have lost patent protection. The market is driven by significant unmet medical need. The prospective growth is expected to be driven by favorable factors such as increased prevalence among world population, limited number of treatment options, need of new regulatory approved medication, and increase in the world geriatric population. Future market growth is particularly expected in Asia Pacific region where the prevalence of GERD therapy is increasing gradually.

This research study includes an extensive analysis of the GERD therapy market by drug class, route of administration, dosage form, devices and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. The market report presents a detailed and investigative study of the entire market and provides a comprehensive insight into various forms of developments, trends and key participants.

While highlighting the key driving and restraining forces for this established market, the report also provides a comprehensive section on competitive landscape, market share analysis, pipeline analysis, competitor benchmarking, and their positioning within the GERD therapy market.

The answers to the following key questions can be found in the report:

  • What are the major market drivers, challenges and opportunities of the global GERD therapy market?
  • How is the GERD therapy market evolving during the forecast period?
  • What are the driving and restraining factors in the GERD market?
  • What will be the market shares of drugs & devices of the global GERD therapy market by 2023?
  • How will each segment of the GERD therapy market grow over the forecast period and how much revenue will these account for in 2023?
  • How will the market share of the leading companies change in 2016 and which country will lead the market in 2017?
  • How will the industry evolve during the period between 2017 and 2023?
  • What are the key developmental strategies implemented in different applications across all regions?
  • Which geographical region will lead the global GERD therapymarket by the end of the forecast period?
  • What are the market trends and key developments in this market?
The report includes the profiles of major players in the market that allows the readers to get an insight into the various industry trends. Some of the leading companies in the market are AstraZeneca Plc., Takeda Pharmaceuticals Company Ltd., GlaxoSmithKline, Eisai, Medigus, Medtronic, Johnson &Johnson, and Endogastric Solutions.

Please note: * The single user license comes with a password which can be used only by the designated user to view the file. This format does not allow the user to copy or print the document, or to share the password with anyone other than the user.

Executive Summary
1 Report Scope & Methodology
1.1 Scope of the Report
1.2 Global GERD Drugs and Devices Market Segmentation
1.3 Key Objectives
1.4 Research Methodology
1.4.1 Data Triangulation
1.4.2 Secondary Sources
1.4.3 Primary Sources
1.4.4 Top-Down Approach
1.4.5 Bottom-Up-Approach
1.4.6 Assumptions and Limitations
1.4.7 Data and Prediction Modelling
2 Market Overview
2.1 Introduction
2.2 Phenotypic Classification of GERD
2.3 GERD Prevalence
2.5 Treatment Options
3 Market Dynamics
3.1 Market Drivers
3.2 Market Challenges
3.3 Market Opportunities
4 Drug Pipeline Analysis
5 Competitive Landscape
5.1 Key Developments & Strategies
5.2 Market Share Analysis
6 Industry Analysis
6.1 Regulatory Bodies and Associations
6.2 Patent Landscape
7 Global GERD Drug Market by Route of Administration,
7.1 Market Overview
7.2 Oral
7.3 Parenteral
8 Global GERD Drug Market by Dosage Form,
8.1 Market Overview
8.2 Solid
8.3 Liquid
9 Global GERD Market by Drug Type,
9.1 Market Overview
9.2 GERD Drug Market by Geography
9.3 GERD Drug Market by Type
9.3.1 H2 Receptor Antagonist
9.3.2 Proton Pump Inhibitor (PPIs)
9.3.3 Antacids
9.4 Patent Expiry & Generic Launch of Major Brands
10 Global GERD Market by Device Type,
10.1 Market Overview
10.2 GERD Device Market by Geography
10.3 GERD Device Market by Type
10.3.1 MUSE –Medigus Ultrasonic Surgical Endostapler
10.3.2 LINX Management System
10.3.3 Stretta Therapy
10.3.4 Bravo Reflux Testing System
10.3.5 Digitrapper reflux testing system
10.3.6 Others
11 Global GERD Drug and Devices Market by Region,
11.1 Geographical Scenario
11.2 North America
11.2.1 North America GERD Drug Market by Country The U.S. Canada
11.3 Europe
11.3.1 Europe GERD Drug Market by Country Germany France The U.K. Italy Norway Sweden Switzerland Finland Rest of Europe (RoE)
11.4 Asia Pacific (APAC)
11.4.1 APAC GERD Drug Market by Country China Japan India Australia Taiwan Rest of Asia Pacific (RoAPAC)
11.5 Rest of the World (RoW)
12 Company Profiles
12.1 AstraZeneca PLC
12.1.1 Overview
12.1.2 Financials Financial Summary
12.1.3 SWOT Analysis
12.2 Johnson & Johnson
12.2.1 Overview
12.2.2 Financials Financial Summary
12.2.3 SWOT Analysis
12.3 Pfizer Inc.
12.3.1 Overview
12.3.2 Financials Financial Summary
12.3.3 SWOT Analysis
12.4 Takeda Pharmaceutical Company Limited
12.4.1 Overview
12.4.2 Financials Financial Summary
12.4.3 SWOT Analysis
12.5 Novartis AG
12.5.1 Overview
12.5.2 Financials Financial Summary
12.5.3 SWOT Analysis
12.6 Merck & CO., Inc.
12.6.1 Overview
12.6.2 Financials Financial Summary
12.6.3 SWOT Analysis
12.7 GlaxoSmithKline Plc
12.7.1 Overview
12.7.2 Financials Financial Summary
12.7.3 SWOT Analysis
12.8 Eisai Co., Ltd.
12.8.1 Overview
12.8.2 Financials Financial Summary
12.8.3 SWOT Analysis
12.9 Boston Scientific Corporation
12.9.1 Overview
12.9.2 Financials Financial Summary
12.9.3 SWOT Analysis
12.10 Ironwood Pharmaceuticals, Inc.
12.10.1 Overview
12.10.2 Financials Financial Summary
12.10.3 SWOT Analysis
12.11 Valeant Pharmaceuticals International, Inc.
12.11.1 Overview
12.11.2 Financials Financial Summary
12.11.3 SWOT Analysis
12.12 Cempra Inc.
12.12.1 Overview
12.12.2 Financials Financial Summary
12.12.3 SWOT Analysis
12.13 Teva Pharmaceuticals Industries Limited.
12.13.1 Overview
12.13.2 Financials Financial Summary
12.13.3 SWOT Analysis
12.14 Medtronic Inc.
12.14.1 Overview
12.14.2 Financials Financial Summary
12.14.3 SWOT Analysis
12.15 Medigus Ltd.
12.15.1 Overview
12.15.2 Financials Financial Summary
12.15.3 SWOT Analysis
12.16 EndoGastric Solutions Inc.
12.17 EndoStim Inc.
12.18 Jeil pharmaceutical Co. Ltd.
12.19 Mederi Therapeutics Inc.
12.20 Torax Medical
List of Tables
Global Gastro-Esophageal Reflux Disease (GERD) Market (2016 &

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook